Ping Cao from 3744 Sipes Ln, Charlotte, NC 28269, age 72, Phone: (704) 598-6886

Resumes

Ping Cao

View page

Location:

Atlanta, GA

Industry:

Restaurants

Ping Cao

View page

Location:

Charlotte, NC

Industry:

Restaurants

Work:

Forturn Cookie
Manager

Ping Cao

View page

Ping Cao

View page

Ping Cao

View page

Ping Cao Stony Brook, NY

View page

Work:

Stony Brook University

2008 to 2000
Research Assistant
NYU Medical Center, School of Medicine
New York, NY
Apr 2011 to May 2012
Visiting Scientist

Education:

Stony Brook University
2007 to 2000
Ph.D. in Chemistry
School of Life Science, Nanjing University
2005 to 2007
M.S.
Nanjing University
2001 to 2005
B.S. in Department of Chemistry

Skills:

protein and peptide chemistry, solid-phase peptide synthesis, expression, purification and characterization of proteins fluorescence spectroscopy. HPLC, gel filtration chromatography, UV-Vis absorption spectroscopy, LC/MS, MALDI-TOF mass spectrometry, analytical ultracentrifugation, dynamic light scattering, circular dichroism and transmission electron microscopy. cell and tissue cultures, molecular and cellular assays. computer skills in biochemistry related programs and general data processing and graphic programs.

Business Records

Name / Title

Company / Classification

Phones & Addresses

Ping Cao
Owner

TOYAMA SUSHI, INC
Ret Gifts/Novelties · Gift Shops · Gift, Novelty, & Souvenir Stores

11 W 36 St, New York, NY 10018
(212) 967-9541

Publications

Us Patents

Islet Amyloid Polypeptides With Improved Solubility

View page

US Patent:

20180319860, Nov 8, 2018

Filed:

Jul 11, 2018

Appl. No.:

16/032328

Inventors:

- Albany NY, US
Hui WANG - East Setauket NY, US
Ping CAO - New York NY, US
Andisheh ABEDINI - New York NY, US

Assignee:

The Research Foundation for The State University of New York - Albany NY

International Classification:

C07K 14/575
C07K 14/00
A61K 38/28
A61K 38/22
A61K 38/00

Abstract:

Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.

Islet Amyloid Polypeptides With Improved Solubility

View page

US Patent:

20170051032, Feb 23, 2017

Filed:

May 1, 2015

Appl. No.:

15/308138

Inventors:

- Albany NY, US
Hui WANG - East Setauket NY, US
Ping CAO - New York NY, US
Andisheh ABEDINI - New York NY, US

Assignee:

THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK - Albany NY

International Classification:

C07K 14/575
A61K 38/28
A61K 38/22
C07K 14/00

Abstract:

The present disclosure provides for isolated non-naturally occurring, mutant-human IAPP polypeptides. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. The present disclosure also provides methods and compositions for treating amyloid-based disease in a subject in need thereof, comprising administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof.

Videos & Images